Steve Rannard and Andrew Owen are using nano-technology to make HIV medicine more effective and less expensive. Nanomedicine builds tiny particles of medication designed to drive the drug into the bloodstream more effectively.
Less medicine means lower costs for treatment, which could greatly increase the number of HIV patients that can receive therapy in low to middle income countries.
Nanomedicines could also have a massive impact on the estimated two million children with HIV who are currently subjected to a treatment which includes twice-daily doses of a 42% ABV ethanol propylene-glycol solution – in lay terms, vodka and antifreeze.
How you can help
To bring this ground-breaking new paediatric therapy through clinical trials and onto the market on a not-for-profit basis, Steve and Andrew need to secure £400,000.
If you’d like to contribute to the impact of Steve and Andrew’s work, visit: www.liverpool.ac.uk/giving/priorities/hiv
Listen via Blubrry
You must be logged in to post a comment.
All recent news
PGR training opportunity: ‘Thriving through Change’ three-part webinar series
Helibron Leadership Programme 2020 – First cohort underway
University launches new Crisis Support Fund for students affected by COVID-19
COVID-19: We are not “all in it together”
New hardship fund available for students affected by COVID-19
Liverpool’s response to COVID19: Join us on Friday 29 May 1200-1300 for the STOP COVID Webinar.
For more information visit: https://bit.ly/2TEYAxt
To register visit: https://bit.ly/3c2zTBB
#STOPCOVID #LHPCOVID #COVID19
Front page of our News site this morning 🗞️
Crisis support fund for students as part of our #LivUniCOVID Emergency Response Campaign, & opinion from 3 of our #publichealth experts on #Covid_19 health inequalities.
Find it all here ➡️http://news.liverpool.ac.uk
In our NEW blog @MeredithCrowle1 and Dr Lu Han look at whether 'level playing fields' will derail the Brexit negotiations.
READ it here 🔻
@stjohnscam @Cambridge_Uni @UoLManSchool @LivUni @livuninews